macular dystrophy

基本解釋

Objective To report a large Chinese family with central areolar macular dystrophy and to identify its genetic entity by mutation analysis of candidate genes.
目的報(bào)道一個(gè)少見的中國人中心暈輪狀黃斑營養(yǎng)障礙家系，通過候選基因突變分析探討該家系發(fā)病的分子遺傳學(xué)基礎(chǔ)。
In November Advanced Cell Technology, of Massachusetts, won approval for the trial of a treatment for Stargardt's macular dystrophy, a disease that destroys retinal cells in children.
11月馬薩諸塞州的先進(jìn)細(xì)胞技術(shù)獲得了批準(zhǔn)，進(jìn)行斯塔哈爾特的黃斑營養(yǎng)不良病，一種破壞兒童眡網(wǎng)膜細(xì)胞的疾病的治療試騐。
Alnylam is already testing RNAi therapy for Huntington’s disease and high cholesterol in cell cultures; other researchers are tackling macular degeneration, muscular dystrophy and HIV.
奧尼蘭姆已經(jīng)針對細(xì)胞培養(yǎng)的亨廷頓氏病和高水品膽固醇進(jìn)行了RNAi療法測試；另一些研究人員正在研究解決黃斑變性、肌肉萎縮和艾滋病病毒。